'Cumulative survival' diaporamas de présentation

Table 1.1.1: Stock and Flow of Blood and Marrow Transplantation, 1987-2006

Table 1.1.1: Stock and Flow of Blood and Marrow Transplantation, 1987-2006. *1 patient in year transplant 2001 with no death date *Out of 1174 patients who were transplanted, there were 49 patients with early death before day 30 of transplant. New patients. Alive at 31st Dec. 800. 700.

572 views • 48 slides

Table 1.1.1: Stock and Flow of Blood and Marrow Transplantation, 1987-2005

Table 1.1.1: Stock and Flow of Blood and Marrow Transplantation, 1987-2005. *1 patient in year transplant 2001 with no death date **2 patients with missing outcome status and 1 patient with unknown outcome status

605 views • 47 slides

Survival Analysis

Survival Analysis. Survival Analysis. Statistical methods for analyzing longitudinal data on the occurrence of events.

904 views • 44 slides

Sean Hayes, Director of Fisheries Ecosystem Research Unit, NMFS

Fish Assemblage Metrics: Key Focal Species Physical Habitat Metrics Based On Life History Stage Associations and Population Dynamics; Responses of Native and Invasive Species Populations. ???. Sean Hayes, Director of Fisheries Ecosystem Research Unit, NMFS

518 views • 43 slides

Pulmonary Board Review

Pulmonary Board Review. Dave Brush M.D. 3/15/10. Pulmonary Function Testing. Lung Volumes Normal 80-120 TLC FRC RV Airflow = Spriometry Exp/Insp Loop DLCO Alveolar/Hg surface area of the lung Confounders. Assess Severity. Asthma Syndromes. Occupational Asthma Worst at work

517 views • 29 slides

Analysis of Complex Survey Data

Analysis of Complex Survey Data. Day 4: Survival analysis and Cox proportional hazards models. Nonparametric Survival Analysis. Kaplan-Meier Method (also called Product-Limit Method) Life Table Method (also called Actuarial Method). Nonparametric Survival Analysis.

526 views • 23 slides

BMS 617

BMS 617. Lecture 10: Survival Curves. Survival Data. The term survival data refers to the measurement of the time it takes for an event to happen The event does not have to be death (so the measurement is the amount of time the subject survived)

330 views • 20 slides

Impact of Thromboaspiration during Primary PCI on Microvascular Damage and Infarct Size: Acute and Long term CE-MRI Eva

Impact of Thromboaspiration during Primary PCI on Microvascular Damage and Infarct Size: Acute and Long term CE-MRI Evaluation. GENNARO SARDELLA, MD, FACC ,FESC; . MASSIMO MANCONE, MD; RAFFAELE SCARDALA, MD; CHIARA BUCCIARELLI DUCCI,MD;ANGELO DI ROMA,MD; IACOPO CARBONE,MD*;GIULIA BENEDETTI

426 views • 19 slides

CHAPTER 4 LIVER TRANSPLANTATION

CHAPTER 4 LIVER TRANSPLANTATION. Editors: Dr Ganesalingam A/L Kanagasabai Expert panel: Dr Ganesalingam A/L Kanagasabai (Chairperson) Professor Dr Lee Way Seah Dr Lim Chooi Bee Dr Lim Kin Foong Dr Haniza Binti Omar. New patients. Alive at 31st Dec. 60. 55. 50. 45. 40. 35.

291 views • 15 slides

CHAPTER 3 HEART AND LUNG TRANSPLANTATION

329 views • 15 slides

CHAPTER 6 HOMOGRAFT - HEART VALVE TRANSPLANTATION

221 views • 9 slides

30-Year Follow-Up Study in Patients with Lone Atrial Fibrillation

30-Year Follow-Up Study in Patients with Lone Atrial Fibrillation. Arshad jahangir, MD; Victor Lee, MBBS; Paul A. Friedman, MD; Jane M. Trusty, RN; David O.Hodge, MS; Stephen L. Kopecky, MD; Douglas L. Packer, MD; Stephen C. Hammil, MD; Win-Kuang Shen, MD; Bernard J. Gersh, MBChB, DPhil.

205 views • 7 slides

Combination therapy and the occurence of the composite vascular endpoint

1.00. Combination therapy and the occurence of the composite vascular endpoint. 0.95. 0.90. 0.85. Cumulative survival . Use of aspirin , a statin and > 1 BP-lowering agent: --- yes --- no. 0.80. 0.75. Time ( years ). 0. 2. 4. 6. 8. 10.

96 views • 1 slides

Survival (days)

a. b. 1.0 0.8 0.6 0.4 0.2 0.0. 1.0 0.8 0.6 0.4 0.2 0.0. OV-90 OV-90: CCL2 49. OV-90 OV-90: CCL2 23. Cumulative survival. Cumulative survival. p=0.001. p=0.001. 40 60 80 100. 20 40 60 80 100 120.

97 views • 1 slides

Cumulative Survival

66 views • 1 slides

100

A. VEH 0mg/kg/day. FLX 18 mg/kg/day. 100. OLZ 12 mg/kg/day. 95. 90. % Body Weight. 85. 80. 10. 11. 12. 13. 14. BL. 1. 2. 3. 4. 5. 6. 7. 8. 9. Day of Restriction. B. 110. 100. 90. 80. 70. % Food Intake. 60. 50. 40. 30. 20. 1. 2. 3. 4. 5. 6. 7. 8. 9. BL.

81 views • 1 slides

Cumulative Survival

110 views • 1 slides